Polymeric micelle/nano hydrogel composite matrix as a novel multi-drug carrier
Graphical abstract
A novel drug carrier for multiple cargo was designed and developed for the combinatorial therapy of colorectal cancer. The biocompatibility and biodegradability of micelle/hydrogel composite were employed. wherein, the hydrophobic core was loaded with two complementary chemotherapeutic drugs namely cisplatin and curcumin. To target these drug molecules to their site of action, folic acid was entrapped within the hydrophilic hydrogel made of hydroxyl appetite and was further dispersed onto the hydrophilic tail of the polymeric micelle. Thus, the developed material could act as a potential candidate for the carrier of multiple cargos.
Introduction
Colorectal cancer is the third most common type of cancer in humans [1,2]. Patients in the advanced stage suffer severe physiological changes and require intensive chemotherapy that often results in poor response and significant morbidity. The undesirable effects of intensive chemotherapy on normal cell and the development of multidrug resistance are the main cause of treatment failure. Recent advances in DDS, makes it possible to target cancer cell line using cytotoxic drugs without affecting normal cells. Nano carriers such as micelles, hydrogels, polymeric nanoparticles and liposomes are capable to improve drug distribution and bioavailability with enhanced cytotoxic concentration in the tumor mass with simultaneous drug delivery leading to reduced side effects [3,4].
Biopolymers are widely being used as a raw material for the design of drug delivery formulations because of their outstanding properties such as biocompatibility, non-toxicity, biodegradability and environmental sensitivity [5,6]. Most common biopolymers include chitosan, sodium alginate (SA), guar gum and heparin (HEP) [7,8] and are being widely used for controlled drug delivery applications. However, the flaws, including weak mechanical properties and burst release of drugs is inevitable when pristine biopolymers are used as carriers. The anticoagulant activity of HEP is greatly reduced after the formation of nano particles and its nano particles do not induce significant toxicity after intravenous injection. Hence, for unconventional routes of drug delivery, HEP seems to be a potential precursor [9].
Hydroxyapatite (HAP, Ca10 (PO4)6 (OH)2) is another non-viable and most important bio mineral found in naturally hard tissue. Because of its biocompatibility, bioactivity, nontoxicity, osteo conductivity, non-inflammatory and non-immunogenic properties, it is widely used for biomedical applications [10,11]. HAP nano composite porous scaffolds were fabricated biometrically and their feasibility as a drug delivery carrier for tissue regeneration and wound healing treatment were evaluated previously [12,13].
Micellar carrier systems are investigated to improve drug solubility and stability. Due to toxic and immunogenicity, natural polysaccharides act as substitutes for synthetic polymers in the development of new micelle systems. By grafting hydrophobic moieties to the polysaccharides backbone, self-assembled micelle can be readily formed in aqueous solutions [14,15]. HEP based micelle systems possess wide variety of biological functions such as anticoagulant activity, inhibition of angiogenesis and antitumor development [16]. The over expression of folate receptors in tumor sites is used as a tool for targeting chemo therapeutic drugs. The folate receptor situated in the surface of the cancer cell can combine with FA or its conjugates to form endosomes [17,18]. These conjugated molecules can be further coated with poly ethylene glycol (PEG) to target the folate binding proteins. For conjugating with FA, long chain fatty acids like hexanoic acid, linoleic acid, stearic acid and oleic acid were used in previous studies [19,20]. Up to date, different hydrophobic molecules, such as octaldehyde [15], Palmitic acid and Stearic acid have been grafted with chitosan to get amphiphilic derivatives, so as to form micelles or micelle like self-aggregates as drug carriers.
At low temperature, a thermo reversible and biodegradable polymer in aqueous solutions is in solution mode and becomes a gel at body temperature. This unique property gives hydrogels more significance in drug delivery as drugs, proteins and cells can be easily mixed with polymeric aqueous solutions at low temperature and can be trapped in the gel state upon in vivo administration [20], [21], [22]. The development of hydrogels in polyesters has made great attention, because the copolymers of polylactide (PLA), polyglycolide (PGA) and polyethylene glycol (PEG) have been approved by FDA for in vivo use [23].
Combinatorial use of multiple drugs has immense applications in pharmaceutical field, getting a better outcome than mono chemotherapy [24]. Multi drug delivery involving two or more drugs is emerging as a challenging approach for the treatment of cancer. This combinational therapy approach could significantly reduce multi drug resistance and side effects leading to enhanced therapeutic efficiency. CUR (diferulolylmethane), is a yellow pigment which exhibit antioxidant, anti-inflammatory and anti-cancer properties and has been described as a neuro protector against neurological disorders [25], [26], [27]. Cisplatin (CIS) is another organometallic drug with excellent chemotherapeutic index. Due to its activity, low amounts of drug are administered thereby decreasing the dose. However, neurite growth is a serious side effect of CIS administration owing to the heavy metal intake [28,29]. It is in this scenario that combinatorial approach where, drugs act in unison comes to the fore. As per previous reports, when CUR is used along with CIS, the side effect of CIS is found to be greatly reduced as evident from the in vitro investigation of chemotherapy induced peripheral neuropathy. Derivatives of CUR when used in unison with CIS also proved to be beneficial for simultaneous intracellular delivery to lung cancer [30].
Combinatorial therapy will enhance the drug usage than conventional methods. Since most of the polymer drug nano composite that has been explored were designed for the anticancer therapy [31,32]. Due to extensive chemo therapeutic procedures, it is very normal for a cancer patient to lose bone density and is often prescribed with hydroxyl appetite drugs or calcium supplements. It was in this direction, HAP was selected as the drug carrier. To target the chemotherapeutic agents to tumor sites, FA was hydrogen bonded with HAP hydrogel.
In the present work, all these aspects were severely scrutinized with the aim of developing a highly patient compliant DDS. In the present approach, two drugs were used in unison – CUR and CIS, not only to increase the overall efficiency of the DDS, but also to decrease the side effect of one drug by the other. To ensure better drug encapsulation of dual drugs and to avoid premature leakage, they were entrapped within the hydrophobic core of the PM composed of HEP. The core of the micellar structure was ensured to be large and hydrophobic enough to accommodate simultaneously CIS and CUR by grafting HEP with triethyl tetraamine (TETA) and oleic acid (OA). To sustain the release of these drugs, the hydrophilic tail of the micelle was coated with a hydrogel of HAP, preloaded with FA. Even though, our group itself has reported the combination of micelle/hydrogel composites, the possibility of improving the void space of the micelle to prepare a carrier for multiple cargo is evaluated for the first time. All steps were carefully monitored using FT-IR, XRD, DLS and SEM analysis. Swelling studies were conducted at different pH level which revealed the swelling dependency of the material in drug release. The cytotoxicity study was performed in colon cancer cell line - HCT116 and results were comparable with the previous literature. To conclude, pH and body temperature favors the release of drugs and it shows toxic effect only in the colon cancer cell lines without affecting the normal cell line. Hence, the prepared material serves to be a promising candidate for the upcoming drug delivery technology.
Section snippets
Materials
HEP (C12H19NO2SO3, CAS No.9041–08–1) and CIS (H6Cl2N2Pt, CAS No.15663–27–1) were procured from TCI Tokyo Chemical Industries Co LTD. FA (CAS No.59–30–3) and NHydroxySuccinimide (NHS, CAS No.6066–82–6) were purchased from Merck (Germany), CUR (C21H20O6, CAS No.458–37–7) was a valuable gift from Alfa Aesar Co Pvt Ltd England. TETA (CAS No. 112–24–3) and 1-(3-Dimethylaminopropyl)−3-ethylcarbodiimide hydrochloride (EDC, CAS No. 25,952–53–8) were obtained from LobaChemie, India and Tokyo Chemical
Results and discussion
This section can be divided into three parts. The first section deals with the characterization of the prepared material using different techniques like FTIR, XRD, DLS, Zeta potential, H1 NMR and SEM. The second section deals with evaluating the efficiency of the material as a drug delivery device wherein, the in vitro drug release, swelling and effect of ionic strength are carefully monitored. The last section deals with realizing the material for real life situations by testing MTT assay and
Conclusions
In the present work, a novel multi-drug carrier of hydrogel micelle composite with multiple payloads were designed and developed. The nano hydrogel was loaded with FA as the targeting ligand to target CIS and CUR, which was loaded onto the hydrophobic core of the PM. All the synthetic strategies were scrutinized using instrumental techniques like FTIR, XRD, NMR, DLS, Zeta potential and SEM. The swelling capabilities of the prepared samples in varying pH and ionic strengths were evaluated. The
Credit author statement
All authors should have made substantial contributions to all of the following.
- •
The acquisition of data, analysis and interpretation.
- •
Drafting the article or revising it critically for important intellectual content
- •
Final approval of the version to be submitted.
Declaration of Competing Interest
The authors declare that we have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
The authors are thankful to Professor and Head, Department of Chemistry, University of Kerala, Trivandrum, India for providing the laboratory facilities.
References (37)
- et al.
Polysaccharides-based nanoparticles as drug delivery systems
Adv. Drug Deliv. Rev.
(2008) - et al.
Carbohydrate molecules: an expanding horizon in drug delivery and biomedicine
Carbohydr. Polym.
(2012) - et al.
Dendronized heparin_doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy
Biomaterials
(2013) - et al.
Development of nanocomposites based on hydroxyapatite/sodium alginate: synthesis and characterization
Mater. Characteriz.
(2011) - et al.
A novel composite MATRIX based on Polymeric micelle and hydrogel as a drug carrier for the controlled release of dual drugs
Carbohydr. Polym.
(2016) - et al.
Bioreducible heparin – based nanogel drug delivery system
Biomaterials
(2015) - et al.
Advances in targeting the folate receptor in the treatment/imaging of cancers
Chem. Sci.
(2018) - et al.
Hydrogels for delivery of bioactive agents: a historical perspective
Adv. Drug Deliv. Rev.
(2013) - et al.
Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: enhanced synergy between cisplatin and demethoxycurcumin against multi drug-resistant stem-like lung cancer cells
Eur. J. Pharm. Biopharm.
(2016) - et al.
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
Int. J. Biochem. Cell Biol.
(2009)
Synthesis characterization and in vivo evaluation of a magnetic cisplatin delivery nanosystem based on PMAA-graft-PEG copolymers
J. Controlled Rel.
Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: a synergistic combination nanotherapy for cervical cancer
Biomed. Pharmacother.
One-pot hydrothermalsynthesis of a magnetic hydroxyapatite nanocomposite for MR imaging and pH-Sensitive drug delivery applications
Heliyon
Nanoparticle assisted solvent selective transdermal combination therapy of Curcumin and 5-flurouracil for the efficient cancer treatment
Carbohydr. Polym.
Enzyme coated beta-cyclodextrin for effective adsorption and glucose-responsive closed-loop insulin delivery
Int. J. Biol. Macromol.
Bioreducible heparin – based nanogel drug delivery system Biomaterials
In-vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetics studies
Eur. J. Pharm. Biopharm.
Current Status and Future Directions in Colorectal Cancer
Indian J. Surg. Oncol.
Cited by (5)
Doxorubicin-loaded mPEG-pPAd-mPEG triblock polymeric nanoparticles for drug delivery systems: Preparation and in vitro evaluation
2023, Journal of Molecular StructurePreparation of new hydrogels by visible light cross-linking of dextran methacrylate and poly(ethylene glycol)-maleic acid copolymer
2023, International Journal of Biological MacromoleculesCitation Excerpt :Biocompatibility is a general term describing the property of a material being compatible with living tissue. A biocompatible biomaterial is a compound that has a cell viability of at least 75 % [72]. In this work, the MTT assay was employed to investigate the cytotoxicity of the prepared hydrogels.
The role of nanotechnology: Organic nanomaterials and the mechanism of cancer phototheranostics
2023, Organic Nanomaterials for Cancer Phototheranostics